InvestorsHub Logo

hemidriver

10/20/17 5:40 PM

#17847 RE: Saltz #17846

I,ve owned dozens of penny stocks over the years and reading the message boards, every one was just days, weeks or at most months away from a buy out. Never once did it happen. Very much like a RS, never seen any good come from one.

ahab333

10/20/17 5:41 PM

#17848 RE: Saltz #17846

Saltz, what an analogy to say the least. Bravo my board friend & GLTU

HCIT

BlueHorseshoe13

10/20/17 5:50 PM

#17849 RE: Saltz #17846

Saltz,
As always, thank you for your insight. Your perspective is invaluable and I could not agree more. The science is our fate, and, in my opinion that question will be answered sooner than the 4-6 week timeline. Once PE is revealed, these conversations will be much different. I believe the results will be game changing.

gestalt2

10/21/17 12:04 PM

#17859 RE: Saltz #17846

Thanks Saltz for this post, your example paints a picture of the BO scenario rather than just looking at it as a black/white event. I must assume the pharm. industry is aware of pro 140 and is watching its progress from different points of view. Every BP has people on the payroll whose job it is to know what is going through clinical trials. Those employees must bring up the treatments that have a large potential market and can take market from existing treatments or there jobs are pointless. How would it be possible that a treatment that is in a multi billion growing market simply disappear with know one ever at any point seeing value from some perspective? The thought that pro 140 will continue to go through p3 trials, complete trials, file BLA and be on the market with not one pharmaceutical wanting to be a part of it is insane. It does not matter from what perspective the pharm is interested, protecting their market, getting into the market or replacing their current declining pipeline. Pro 140 can only fail if there is bad results in the data, a safety concern or they run out of money. Not one of these has been a problem in many years of injecting patients of all types and there has not been a rumor that CYDY is having trouble getting money.